Search research articles
Contact Us
Filters
Showing results (231-240 of 302) with videos related to
Page
of 31
Sort By:
Nuclear Medicine and Biology
|
August 6, 2003
Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine
H Orlefors, A Sundin, K J Fasth, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
January 1, 1988
Effect of interferon on T1 relaxation times of liver metastases from endocrine gastrointestinal tumours
T Andersson, B Eriksson, A Hemmingsson, et al.
Nuclear Medicine and Biology
|
April 8, 2000
Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography
A Sundin, B Eriksson, M Bergström, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1994
Interferon treatment of neuroendocrine tumour xenografts as monitored by MRI
A Elvin, K Oberg, P G Lindgren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1992
Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: a randomized trial
E T Janson, L Rönnblom, H Ahlström, et al.
Nordisk Medicin
|
December 4, 1998
[PET in neuroendocrine tumors]
B Eriksson, H Orlefors, A Sundin, et al.
Akusherstvo I Ginekologiia
|
February 1, 1988
[Excretion of catecholamines in the urine and serotonin levels of the blood during anesthesia in labor using the methods of reflexotherapy]
V F Markelova, R A Belitskaia, O K Oberg, et al.
Medical Oncology (Northwood, London, England)
|
May 25, 2002
Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs
M L Fjällskog, A Sundin, J E Westlin, et al.
Cancer Research
|
December 1, 1995
Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers
K M Kälkner, E T Janson, S Nilsson, et al.
The American Journal of Pathology
|
January 1, 1993
Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease
J Waltenberger, L Lundin, K Oberg, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 302) with videos related to
Sort By:
Page
of 31
Nuclear Medicine and Biology
|
August 6, 2003
Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine
H Orlefors, A Sundin, K J Fasth, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
January 1, 1988
Effect of interferon on T1 relaxation times of liver metastases from endocrine gastrointestinal tumours
T Andersson, B Eriksson, A Hemmingsson, et al.
Nuclear Medicine and Biology
|
April 8, 2000
Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography
A Sundin, B Eriksson, M Bergström, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1994
Interferon treatment of neuroendocrine tumour xenografts as monitored by MRI
A Elvin, K Oberg, P G Lindgren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1992
Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: a randomized trial
E T Janson, L Rönnblom, H Ahlström, et al.
Nordisk Medicin
|
December 4, 1998
[PET in neuroendocrine tumors]
B Eriksson, H Orlefors, A Sundin, et al.
Akusherstvo I Ginekologiia
|
February 1, 1988
[Excretion of catecholamines in the urine and serotonin levels of the blood during anesthesia in labor using the methods of reflexotherapy]
V F Markelova, R A Belitskaia, O K Oberg, et al.
Medical Oncology (Northwood, London, England)
|
May 25, 2002
Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs
M L Fjällskog, A Sundin, J E Westlin, et al.
Cancer Research
|
December 1, 1995
Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers
K M Kälkner, E T Janson, S Nilsson, et al.
The American Journal of Pathology
|
January 1, 1993
Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease
J Waltenberger, L Lundin, K Oberg, et al.
Page
of 31